FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      CICC Initiates Coverage of Pfizer Inc. with Outperform Rating

      CICC has begun coverage of Pfizer Inc. (NYSE:PFE), assigning the pharmaceutical company an Outperform rating and establishing a price target of $33. This rating reflects CICC's positive outlook on the company's potential performance in the market.

      In related news, Pfizer recently released topline results from its Phase 3 VALOR trial, which focuses on a vaccine against a specific disease. The announcement was made on March 23, highlighting the company's ongoing commitment to advancing its vaccine development initiatives.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud